全文获取类型
收费全文 | 823篇 |
免费 | 276篇 |
国内免费 | 53篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 19篇 |
妇产科学 | 20篇 |
基础医学 | 269篇 |
口腔科学 | 17篇 |
临床医学 | 71篇 |
内科学 | 118篇 |
皮肤病学 | 13篇 |
神经病学 | 40篇 |
特种医学 | 14篇 |
外科学 | 170篇 |
综合类 | 103篇 |
预防医学 | 15篇 |
眼科学 | 8篇 |
药学 | 90篇 |
中国医学 | 7篇 |
肿瘤学 | 169篇 |
出版年
2024年 | 15篇 |
2023年 | 24篇 |
2022年 | 58篇 |
2021年 | 102篇 |
2020年 | 99篇 |
2019年 | 94篇 |
2018年 | 93篇 |
2017年 | 102篇 |
2016年 | 63篇 |
2015年 | 107篇 |
2014年 | 73篇 |
2013年 | 63篇 |
2012年 | 57篇 |
2011年 | 49篇 |
2010年 | 19篇 |
2009年 | 15篇 |
2008年 | 3篇 |
2007年 | 1篇 |
2006年 | 2篇 |
2005年 | 2篇 |
2003年 | 2篇 |
2002年 | 2篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1998年 | 1篇 |
1997年 | 5篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1985年 | 13篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1976年 | 8篇 |
1975年 | 4篇 |
1974年 | 7篇 |
1973年 | 1篇 |
排序方式: 共有1152条查询结果,搜索用时 203 毫秒
61.
E. K. Boukas 《Optimal control applications & methods.》2009,30(5):477-494
This paper deals with the class of discrete‐time linear systems with random abrupt changes and unknown transition probabilities but varying between known bounds for each mode. The ℋ︁∞ control problem of this class of systems is revisited and new sufficient conditions are developed in the linear matrix inequality (LMI) setting to design the state‐feedback controller that stochastically stabilizes the system under consideration and at the same time guarantees the disturbance rejection with a desired level γ . Sufficient conditions for existence of the state‐feedback controller are developed. It is shown that the addressed problem can be solved if the corresponding developed LMIs are feasible. Numerical examples are employed to show the usefulness of the proposed results. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
62.
MicroRNA-224在肝癌HepG2细胞中的表达及其靶基因的预测分析 总被引:1,自引:1,他引:0
目的 应用基因芯片技术研究microRNA-224在肝癌HepG2细胞中的表达,通过生物信息学预测其下游靶基因,并初步揭示其在肝癌发生过程中的作用.方法 利用基因芯片技术筛选得到和正常肝上皮LO2细胞比较差异表达的基因,通过生物信息学预测表达上调的microRNA-224的靶基凶,并对其靶基因进行功能注释.结果 与LO2细胞比较,microRNA-224在肝癌HepG2细胞中旱高表达.MicroRNA-224预测靶基因有264个,其多个基因涉及细胞周期、信号转导、细胞增殖、细胞分化和细胞凋亡等众多生物学过程.结论 MicroRNA-224在肝癌HepG2细胞中呈现高表达,可能间接或直接地调控其下游靶基因表达,在肝癌发生过程中起着重要的作用. 相似文献
63.
Baolong Zhu Mingliang Suo Zhiping Zhang Min Li Shunli Li 《Optimal control applications & methods.》2018,39(3):1158-1167
This work investigates the problem of L2‐L∞ filtering for a class of stochastic nonlinear systems with nonuniform sampling. The sampled‐data filter developed in this paper is an impulsive differential system whose states change abruptly at every sampling instant. The resulting filtering error system is modeled as a stochastic nonlinear impulsive differential system. The goal is to propose a method for designing a target filter that ensures the stochastic asymptotic stability of the filtering error system and guarantees a prescribed L2‐L∞ performance. Based on a time‐varying Lyapunov functional, by virtue of a convex combination technique, a design method to achieve such a filter is formulated in the form of solving a set of linear matrix inequalities. The effectiveness of the proposed filtering strategy is shown via a numerical example of a stochastic Chua's circuit system. 相似文献
64.
R C Strange J Reid D Holton N P Jewell I W Percy-Robb 《Clinica chimica acta; international journal of clinical chemistry》1980,103(3):317-323
Several reports have been published commending the use of 14C-labelled triglyceride breath tests in the assessment of fat malabsorption. We report further studies using gyceryl [14C]tripalmitate. Corrections for age, weight or metabolic rate failed to improve the test's ability to discriminate between malabsorbers and control subjects. A correction for respiratory quotient improved the linear correlation observed between the breath test results and daily faecal fat excretion. The significance of these findings is discussed and a number of problems identified which, at present, are preventing the introduction of breath tests for fat malabsorption into routine clinical practice. 相似文献
65.
Zhenwei Lei Xin Ma Hongzhao Li Yu Zhang Yu Gao Yang Fan Xintao Li Luyao Chen Yongpeng Xie Jianwen Chen Shengpan Wu Lu Tang Xu Zhang 《Urologic oncology》2018,36(3):93.e23-93.e37
Objectives
Dysregulated expression of miR-181a accompanies tumorigenesis in many human cancers. However, in clear cell renal cell carcinoma (ccRCC), the role of miR-181a remains unclear. The aim of this study was to investigate biological functions of miR-181a and its expression levels in ccRCC tissues and cancer cell lines.Material and methods
Expression levels of miR-181a in samples of ccRCC tumors and adjacent nontumor tissues from 42 patients as well as in 786-O, 769-P, A498, and CAKI-1 ccRCC cell lines were determined by quantitative real-time polymerase chain reaction. Potential targets of miR-181a were predicted using bioinformatic approaches and then verified by using the luciferase reporter assay. The effects of miR-181a on cell proliferation, colony formation, cell cycle progression, and apoptosis were investigated in ccRCC cell lines transfected with specific miR-181a mimic and inhibitor.Results
We found that miR-181a expression was up-regulated in ccRCC tissues and cell lines. The expression level of miR-181a significantly correlated with the tumor size, tumor/node/metastasis staging, and Fuhrman grade. Luciferase assays showed that KLF6 was a target of miR-181a. KLF6 expression was inversely correlated with the level of miR-181a. Overexpression of miR-181a led to reduced KLF6 mRNA and protein levels, whereas mutations of the potential miR-181a binding sites in the KLF6 gene abrogated this inhibitory effect. Furthermore, overexpression of miR-181a promoted proliferation and G1/S cell cycle transition, as well as inhibited apoptosis by down-regulating KLF6 in ccRCC cells.Conclusions
miR-181a is up-regulated in ccRCC and may act as a tumor promoting factor by targeting KLF6 expression. Manipulating miR-181a may provide a beneficial effect in the treatment of ccRCC. 相似文献66.
Daniel W. Lin E. David Crawford Thomas Keane Brent Evans Julia Reid Saradha Rajamani Krystal Brown Alexander Gutin Jonathan Tward Peter Scardino Michael Brawer Steven Stone Jack Cuzick 《Urologic oncology》2018,36(6):310.e7-310.e13
Background
A combined clinical cell-cycle risk (CCR) score that incorporates prognostic molecular and clinical information has been recently developed and validated to improve prostate cancer mortality (PCM) risk stratification over clinical features alone. As clinical features are currently used to select men for active surveillance (AS), we developed and validated a CCR score threshold to improve the identification of men with low-risk disease who are appropriate for AS.Methods
The score threshold was selected based on the 90th percentile of CCR scores among men who might typically be considered for AS based on NCCN low/favorable-intermediate risk criteria (CCR = 0.8). The threshold was validated using 10-year PCM in an unselected, conservatively managed cohort and in the subset of the same cohort after excluding men with high-risk features. The clinical effect was evaluated in a contemporary clinical cohort.Results
In the unselected validation cohort, men with CCR scores below the threshold had a predicted mean 10-year PCM of 2.7%, and the threshold significantly dichotomized low- and high-risk disease (P = 1.2 × 10–5). After excluding high-risk men from the validation cohort, men with CCR scores below the threshold had a predicted mean 10-year PCM of 2.3%, and the threshold significantly dichotomized low- and high-risk disease (P = 0.020). There were no prostate cancer-specific deaths in men with CCR scores below the threshold in either analysis. The proportion of men in the clinical testing cohort identified as candidates for AS was substantially higher using the threshold (68.8%) compared to clinicopathologic features alone (42.6%), while mean 10-year predicted PCM risks remained essentially identical (1.9% vs. 2.0%, respectively).Conclusions
The CCR score threshold appropriately dichotomized patients into low- and high-risk groups for 10-year PCM, and may enable more appropriate selection of patients for AS. 相似文献67.
BackgroundThe accessibility of public facilities for all is an issue increasingly gaining focus in policy debates, especially regarding the ageing population.ObjectiveThis paper describes a psychometric approach to the development of a new instrument for assessing the accessibility of public entrances.MethodsItems to include were selected by means of literature review and classified according to a typology of person-environment fit that uses the International Classification of Functioning, Disability and Health (ICF) as theoretical framework. Content validity was assessed by a scientific panel approach and construct validity by using simulation techniques and correlation analysis with a related construct. Reliability was evaluated by inter-rater agreement analysis, where 15 strategically selected public entrances were assessed by five rater pairs.ResultsContent validity was assessed as high (3.6 on a scale from 1 to 4) and correlation indicating convergent validity between instrument scores and a related construct was moderate (rs = 0.60, p < 0.001). Inter-rater reliability was acceptable to good (kappa 0.42, overall agreement 81%). After an iterative process including review of validity and reliability results, the resulting assessment instrument consisted of 56 items in 7 sections.ConclusionsThis study demonstrated good content validity and acceptable to good inter-rater reliability. Though initial results were promising, user involvement and further testing of construct validity is needed. The goal of the new instrument is a feasible tool for planning, evaluation and accomplishment of policies intended to make public entrances accessible for all. The extent to which the instrument succeeds remains to be tested by practical use. 相似文献
68.
《Immunobiology》2022,227(6):152295
ObjectivePrevious works have outlined the pivotal involvement of long intergenic non-coding RNA (lincRNA) in cancer progression, while the efficiency of LINC01234 in pancreatic cancer remained obscure. The purpose of this research is to unravel the regulatory mechanism of LINC01234 in pancreatic cancer via modulating microRNA (miR)-513a-3p and hexose 6-phosphate dehydrogenase (H6PD).MethodsPancreatic cancer cells were cultured and clinical tissue specimens were collected. LINC01234, miR-513a-3p and H6PD levels in pancreatic cancer cells and tissues were examined. Plasmids altering LINC01234, miR-513a-3p and H6PD expression were transfected into pancreatic cancer cells to assess the change in biological behaviors of pancreatic cancer cells. The targeting relations among LINC01234, miR-513a-3p and H6PD were validated.ResultsLINC01234 and H6PD levels were elevated while miR-513a-3p level was reduced in pancreatic cancer cells and tissues. LINC01234 deficiency hindered the malignant biological activities of pancreatic cancer cells. MiR-513a-3p depletion or H6PD elevation could abrogate the inhibitory effects of LINC01234 silencing on pancreatic cancer cells. LINC01234 sponged miR-513a-3p that targeted H6PD.ConclusionThe reduced LINC01234 exerts inhibitory impacts on pancreatic cancer cells via targeting miR-513a-3p to restrain H6PD level. The current study broadens the understanding of LINC01234 function and affords novel therapeutic targets for pancreatic cancer treatment. 相似文献
69.
miR-451对胶质瘤细胞株A172生物学特征的影响 总被引:1,自引:1,他引:0
目的 研究miR-451对胶质瘤细胞株A172生物学特征的影响.方法 合成寡核苷酸miR-451拟似物(miR-451 mimics)转染胶质瘤细胞以上调miR-451的表达,real-time PCR检测转染后miR-451的表达,Western印迹法检测目标蛋白表达,应用流式细胞术、MTT法评价细胞生长和增殖的生物学特征变化.结果 转染miR-451 mimics后,real-time PCR检测提示miR-451表达升高,Western blot结果显示癌基因C-myc表达下降>63.6%,细胞周期正向调节因子CDK2、CDK4、Cyclin D1和Cyclin E表达下降;细胞周期分析表明miR-451 mimics组进入G0/G1期的细胞数较对照组增多达17.4%,出现G0/G1期阻滞;MTT法分析显示miR-451 mimics组细胞生长受抑.结论 miR-451可以抑制人脑胶质瘤细胞生长和增殖能力,具有抑瘤作用. 相似文献
70.